Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review)

Published:2021-02-08 Issue:4 Volume:23 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Tao Qian-Ru¹,Chu Ying-Ming²,Wei Lan³,Tu Chao³,Han Yuan-Yuan⁴

Affiliation:

1. Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China

2. Department of Integrated Traditional Chinese Medicine, Peking University First Hospital, Beijing 100034, P.R. China

3. Department of Internal Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, P.R. China

4. Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan 650118, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Angiogenic-Antioxidant Activity and Anti-diabetic Histological Impacts of Chitosan-Coated Anethole Nano-phytosomes (CCA-NPs) on the Diabetic Rats’ Pancreatic Tissue and Blood Biochemistry Indices;BioNanoScience;2024-03-26

2. Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

3. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease;Clinical Journal of the American Society of Nephrology;2023-08-03

4. Still finding ways to augment the existing management of acute and chronic kidney diseases with targeted gene and cell therapies: Opportunities and hurdles;Frontiers in Medicine;2023-03-07

5. Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy;Biomedicine & Pharmacotherapy;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3